Dr Stanley Hazens

Dr. Stanley Hazen received his clinical training in Internal Medicine and sub-specialty training in Diabetes, Endocrinology and Metabolism at Barnes/Jewish Hospital, and a PhD in Biophysical Chemistry and Molecular Biology from Washington University School of Medicine, St. Louis, MO. He holds multiple leadership positions at the Cleveland Clinic including chair, Department of Cardiovascular & Metabolic Sciences, co-section head, Preventive Cardiology & Rehabilitation, and Director, Center for Microbiome & Human Health.

Dr. Hazen (H-index 150; citations >170,000) has published >500 articles in basic and clinical journals alike in the fields of cardiovascular disease (CVD), lipid metabolism and inflammation. He has made pioneering discoveries in mechanisms contributing to cardiovascular and inflammatory diseases, including the seminal discovery linking gut microbial pathways to CVD pathogenesis. His research in multiple areas has impacted clinical practice and lays the foundation for both FDA- and EU-cleared diagnostic tests for CVD risk assessment in use worldwide. His research has also helped to spawn pharmaceutical development of CVD drugs in clinical trials.

Dr. Hazen is an elected fellow to both the National Academy of Medicine, USA, and the American Association for the Advancement of Science. He also is an elected member of the American Association of Physicians.

External